CHARLENE REYNOLDS: Open Payments
NPI 1629617774 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 63 payments from 10 companies in 2025. Trend: 2023 $890 · 2024 $629 · 2025 $1,145
Food & beverage: $1,033Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $226 |
| E.R. Squibb & Sons, L.L.C. | 18 | $214 |
| Neurocrine BioSciences, Inc. | 12 | $189 |
| Otsuka America Pharmaceutical, Inc. | 9 | $151 |
| Janssen Pharmaceuticals, Inc | 6 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 4 | $72 |
| Alkermes, Inc. | 3 | $57 |
| Janssen Scientific Affairs, LLC | 1 | $39 |
| Janssen Biotech, Inc. | 1 | $35 |
Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY, CAPLYTA, FANAPT, ARISTADA.
Industry payments across FL — which companies pay providers there.
